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necessary to remove the biliary external drainage to 
enable complete recovery from his symptoms. 
Microbiologists should be aware of the existence of 
this fastidious microorganism and its potential patho- 
genic role, especially when it is isolated from immuno- 
compromised patients. 
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Nasopharyngeal carriage of drug-resistant Streptococcus 
pneumoniae among children in Oman 
Clin Microbiol Infect 1998; 4: 346-349 
Since the late 1970s, penicillin-resistant pneumococci 
(PRP) have become prevalent worldwide, and pneumo- 
coccal strains with decreased sensitivity to benzyl- 
penicillin, as well as other antimicrobial agents, have 
been reported from many countries [l-31. High 
carriage rates of PRP in the community have been 
shown to result in an increased incidence of clinical 
infection [4], and healthy children have been found to 
be an important reservoir [5,6], as they often harbor 
pneumococci in their upper respiratory tracts. Oman 
has a population of 2 135 900, about half of whom are 
under 15 years of age. Children under 5 years represent 
15.7% of the population [7]. With such a large child 
population, high pneumococcal carriage rates can result 
in a very high incidence of pneumococcal infections. 
As there are no data on the prevalence of drug-resistant 
pneumococci (DRP) in Oman, we carried out this 
survey in order to determine the nasopharyngeal 
carriage rate of Streptococcus pneumoniae among children 
and the prevalence of D R P  in this country. 
Children who were attending the pediatric referral 
clinic at the Royal Hospital, Muscat, during the period 
from October 1996 to January 1997 were studied. 
Consent was obtained from the participants’ parents or 
guardians. For detection of carriers, nasopharyngeal 
material was collected on calcium alginate swabs on 
flexible aluminum shafts. Swabs were inoculated onto 
blood agar plates, which were incubated at 36OC in 
5-10% COz for 24 h. a-Hemolytic colonies inhibited 
by optochin (inhibition zone extending radially for at 
least 5 rnm from the edge of the disk) were identified 
as S. pneumoniae [8]. All 108 strains were tested for 
sensitivity to benzylpenicfin, and the first 80 isolates 
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were further tested against co-amoxiclav, cefuroxime, 
cefaclor, ceftriaxone and clarithromycin. Although 
amoxycillin is the active ingredient against S. pnetrmoniae, 
we tested co-amoxiclav because it is used empirically 
in the treatment of otitis media and other respiratory 
tract infections, where P-lactamase-producing organisms 
such as Haemophiltrr inzuenzae are often involved. 
Antibiotic susceptibility testing was performed on 
Mueller-Hinton agar supplemented with 5% sheep 
blood, by the E-test method, used according to 
the manufacturer’s instructions. S. pneumoniae ATCC 
49619 control organism was included with each 
batch. Susceptibilities to antibiotics were determined 
according to NCCLS breakpoint standards [9j. Differ- 
ences between two variables were assessed by the 
Student’s t-test. A t value of >1.96 was considered to 
be statistically significant. 
Two hundred and eighty-six children (1 63 male; 
123 female) were enrolled in this study. Their ages 
ranged from 2 months to 14 years, with a mean age of 
5 years and 2 months (62 months). Twenty-four 
children were < 1 year old, 76 were in the age group 1 
to < 3  years, 54 in the age group 3-5 years and the 
remaining 132 over 5 years old. S. pneumoniae was 
recovered from the nasopharynx of 108 (37.8%; 58 
male; 50 female). There was no significant difference 
in pneumococcal carriage rate between male and 
female children (t =0.87), but there were significant 
differences in relation to age. The age groups 1 to < 3  
and 3-5 years showed significantly hgher carriage rates 
than the age groups <1 year (t=3.16 and 2.38 respec- 
tively) and > 5  years (t=3.43 and 2.23 respectively). 
There was no significant difference between the age 
groups 1 to < 3  and 3-5 years (t=0.71) or <1 and >5 
years (t=0.87) (Table 1). 
Fifty-nine (54.63%) strains of S. pneumoniae were 
resistant to benzylpenicillin (MIC 0.03-2.0 mg/L; 
MICso 0.1 mg/L; 0.5 mg/L). Of these, five 
(4.63%) strains were defined as highly resistant to 
benzylpenicillin (MIC > 1.0 mg/mL) and 54 were 
intermediately so (MIC 0.1-1.0 mg/L). PRP was 
harbored by 20.6% of the children and the carriage 
rate was significantly higher among the age groups 1 to 
Table 1 Pneumococcal carriage rate in  children of 
different age groups 
Age Number of Number and Number and % 
children % of carriers of PRP carriers 
<1 year 24 5 (20.8%) 3 (12.5%) 
1 to 1 3  years 76 40 (52.6%) 22 (28.9%) 
3-5 years 54 25 (46.3%) 16 (29.6%) 
> 5 years 132 38 (28.8%) 18 (13.6%) 
AU age groups 286 108 (37.8%) 59 (20.6%) 
< 3  year:; and 3 to 5 years than among those > 5  years 
(tz2.55, and 2.32 respectively), but there was no 
significant difference between the remaining age 
groups. ‘The MICso and MIC90 of the various anti- 
microbial agents against benzylpenicillin-sensitive and 
benzylpenicillin-resistant strains and the number of 
strains resistant to the tested antimicrobial agents are 
shown in Table 2. MICso and MIC90 of all antibiotics 
were considerably higher in benzylpenicillin-resistant 
than in benzylpenicillin-sensitive strains. Five per cent 
of pneumococcal strains were resistant to co-amoxiclav, 
22.5% to cefuroxime, 6.25% to ceftriaxone, 71.25% 
to cefaclor and 25% to clarithromycin. Eighty-eight per 
cent of the strains resistant to clarithromycin had MICs 
of >250 mg/L. 
The nasopharyngeal carriage rate of S. pneumoniae 
in Oman appears to be high, but is still comparable to 
that in some other countries [10,11]. Most reports, 
however, have shown wide variation in pneumococcal 
carriage rate in relation to time spent in day- 
care facilities, occurrence of pneumococcal infection 
among the studied group, hospitalization and recent 
antibiotic treatment [10,11]. Our data, on the other 
hand, were obtained from a heterogeneous, scattered 
group of children from all over the country, which 
should reflect a true picture of pneumococcal carriage 
in Oman. 
Like other workers, we found no significant 
difference in sex distribution between carriers and non- 
carriers of S. pneumoniae [3,12], but more frequent 
carriage in children between the age of 1 and 5 years 
than in cilder children [13,14]. However, others have 
also found infants &om day-care centers to be kequent 
carriers. The lower carriage rate among infants in our 
series is probably due to the fact that children of this 
age, in Oman, do not attend day-care centers and thus 
are unlikely to mix with other children from whom 
they could contract pneumococci. 
Resistance of S. pneumoniae to cephalosporins in 
our series is consistent with the findings of other 
workers [3,15j, and the high resistance rate to cefaclor 
confirms the views ofKlugman and Friedland [16] that 
cefaclor has no useful activity against PRP. Co- 
amoxiclav showed the highest activity, inhibiting 95% 
of our strains. In fact, amoxycillin has been shown to 
be more active against PRP than any oral cephalosporin 
[16]. In t.his study, the MIC values obtained with co- 
amoxiclav should represent those of amoxycillin, as the 
addition of clavulanate has been shown not to influence 
the MIC d amoxycillin against S. pneumoniae [17]. The 
resistance rate to macrolides in our series is consistent 
with that in other centers [3]. 
Strains of S. pneumoniae resistant to benzylpenicillin 
in our series showed considerably higher MIC values 
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Table 2 Antibiotic susceptibilities of benzylpenicillin-sensitive and -resistant strains of S. pneumoniae 
Benzylpenicillin sensitive Benzylpenicillin resistant All strains 
(n=39) (n=41) (n = 80) % Resistant strains (“A) 
Antibiotic MICso MICyo MICso MICro MICso MIC9o I R A l l  
Co-amomclav 0.03 0.03 0.12 0.5 0.03 0.25 0 5 5.00 
Cefuroxime 0.06 0.25 9.5 4 0.25 2 11.25 11.25 22.50 
Ceftriaxone 0.03 0.06 0.25 1 0.12 0.5 6.25 0 6.25 
Cefaclor 0.5 1 2 32 1 4 43.75 27.50 71.25 
Clarithromvcin 0.25 0.25 0.25 > 256 0.25 > 256 6.25 18.75 25 
I, intermediate: R,  resistant. 
of all tested antibiotics than benzylpenicfin-sensitive 
strains. As the mechanism of resistance to benzyl- 
penicillin is alteration of penicillin-binding proteins, 
the susceptibilities of other p-lactam agents are also 
diminished [ 171 and macrolide resistance has been 
reported to occur more frequently in penicillin- 
resistant strains of S. pneumoniae [18]. 
With these facts in mind, clinicians in Oman 
should be aware of possible failures in the empirical 
treatment of pneumococcal infections, particularly 
otitis media, in which the causative strain is rarely 
isolated for checking of antibiotic susceptibility. Co- 
amoxiclav appears to be a reasonable choice for otitis 
media, as it contains the oral agent most generally active 
against pneumococci and should also cover infection 
with agents that produce p-lactamases, such as H. 
influenzae. Ceftriaxone, with or without vancomycin, 
depending on the susceptibility of the isolate, remains 
the drug of choice in the treatment of pneumococcal 
meningitis [19]. Additional epidemiologic data, as 
well as data from clinical trials, are essential to deter- 
mine appropriate empirical treatment of pneumococcal 
infections, as pneumococcal resistance t o  currently 
available drugs is rapidly increasing. 
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An outbreak of invasive meningococcal disease probably 
associated with an indoor swimming pool 
Clin Microbiol Infect 1998; 4: 349-350 
From 29 January to 2 May 1996, a cluster of five cases 
of meningococcal disease occurred among children 
aged 1-4 years (Table 1) in Lloret de Mar, a city in 
Catalonia, in the north-east of Spain, with 16 770 
inhabitants. All cases were diagnosed as meningococcal 
sepsis and two died. At first it appeared that there were 
two unrelated sporadic cases and two related cases in a 
school, in the same classroom (Table l), but a more 
careful epidemiologic investigation indicated that all 
chlldren had attended the same swimming pool. The 
total population under 5 years in the city is 1074, and 
only 65 attend this sports club. 
The first two cases attended the sports club for a 
swimming course, with the same monitor, but with a 
different timetable (Table 1). The second and the third 
shared the same classroom, and they used to play 
together. The fourth case was the son of the sports club 
manager. He went every day to the swimming pool to 
meet his mother, and he had a close relationship with 
the monitor in charge of the two first cases because she 
is a very close friend of his mother. In fact, the monitor 
used to spend some minutes every day playing with 
him. The fifth case coincided one day every week at 
the swimming pool with the first two cases, in the 
charge of the same monitor. 
Serogroup B Neisseria meningitidis was isolated from 
all five cases: four isolates from blood and one from 
throat culture. One additional meningococcal strain 
(not included in Table l), isolated from throat 
culture in a household contact of case no. 5, was also 
investigated. Unfortunately, only three meningococcal 
strains isolated from blood culture were retained and 
sent for characterization (sero/subtyping and pulsed- 
field gel electrophoresis (PFGE) analysis) to the National 
Reference Laboratory The serogroup, serotype/subtype 
and the MICs of sulfadiazine, rifampin, penicillin and 
cefotaxiime were determined by the methods already 
described [1,2]. For the PFGE analysis, the isolates 
were cultured on blood agar plates for 18-22 h, and 
bacterial growth was scraped into sodium/EDTA (SE) 
buffer (NaC1, 75 mM; EDTA, 25 mM; pH 7.4; 3 d). 
Specimens were centrifuged and the pellet was re- 
suspended in SE buffer. The cell suspension was mixed 
with an equal volume of melted Sea-Plaque agarose 
(1% (WI'V) in Tris-borate/EDTA (TBE) buffer) at 
42°C and dxectly dispensed into plastic molds at 4°C. 
Solidified blocks were treated with TE buffer (0.01 M 
Tris; 0.001 M EDTA; pH 8.1) supplemented with 
1 mg/mL proteinase K and 1% sarkosyl at 56OC for 
48 h. Blocks were washed with TE buffer for 30 min 
six times at room temperature and stored in this buffer 
at 4OC. Plugs containing chromosomal DNA were 
equilibrated with appropriate restriction enzyme 
buffer, anid digested with 30 units of BglII (Pharmacia) 
overnight. The digested DNA plugs were placed in 
wells of 3% agarose gel prepared in TBE @H 8.2) and 
sealed with 1% agarose at 42OC. PFGE was carried out 
with a contour-clamped homogeneous electric-field 
apparatus (CHEF D R  11; Bio-Rad) with initial to final 
time ranging from 0.1 to 25 s at 200 V for 22 h. Gels 
were stained with ethidium bromide and photographed 
under UV light. 
Three meningococcal strains isolated from blood 
culture were characterized as being the B:4:P1.4 
phenotype, which is not frequent in Spain [2] .  All of 
them showed the same 12-band profile (pattern 
numbered as 1) with PFGE after digestion with BgnI 
enzyme. All isolates showed MICs of sulfadiazine, 
penicillin, rifampin and cefotaxime of 5,0.03,0.03 and 
0.0015 mg/L respectively. These results indicate that at  
least three of the five cases were caused by the same 
strain. Unfortunately, we were not able to characterize 
fully the osther two isolates from patients 1 and 3 (Table 
1). 
In four of the cases, a common relationship with 
the swimming pool monitor was established, but we 
did not investigate carriage in adults working at the 
swimming pool and so we cannot prove that the monitor 
was an asymptomatic carrier of the B:4:P1.4 strain. 
The monitor helped actively in teaching the children 
to swim. She was given chemoprophylaxis when 
her association with the fourth case was recognized. 
Apparently, she took the rifampin as instructed, but two 
